blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1330441

EP1330441 - BENZIMIDAZOLES AND METHODS FOR USE THEREOF IN THE TREATMENT OF CANCER OR VIRAL INFECTIONS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.06.2008
Database last updated on 19.10.2024
Most recent event   Tooltip27.06.2008Application deemed to be withdrawnpublished on 30.07.2008  [2008/31]
Applicant(s)For all designated states
UAF Technologies and Research, LLC
1111 North Cherry Avenue
Tucson, Arizona 85721 / US
[2004/12]
Former [2003/31]For all designated states
The University of Arizona Foundation
111 North Cherry Avenue
Tucson, Arizona 85721 / US
Inventor(s)01 / QUADA, James, C, . Jr.
9818 Hawkwood
San Antonio, TX 78250 / US
02 / AGYIN, Joseph, K.
9618 Cedarstone Creek
San Antonio, TX 78254 / US
03 / CAMDEN, James, Berger
7739 Charter Cup Lane
West Chester, OH 45069 / US
 [2003/31]
Representative(s)Raynor, John, et al
Beck Greener
Fulwood House
12 Fulwood Place
London
WC1V 6HR / GB
[N/P]
Former [2003/31]Raynor, John, et al
W.H. Beck, Greener & Co 7 Stone Buildings Lincoln's Inn
London WC2A 3SZ / GB
Application number, filing date01973190.019.09.2001
[2003/31]
WO2001US29261
Priority number, dateUS2000067016926.09.2000         Original published format: US 670169
US2000067016826.09.2000         Original published format: US 670168
US2000067017026.09.2000         Original published format: US 670170
US2000067016626.09.2000         Original published format: US 670166
[2003/31]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0226716
Date:04.04.2002
Language:EN
[2002/12]
Type: A2 Application without search report 
No.:EP1330441
Date:30.07.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 04.04.2002 takes the place of the publication of the European patent application.
[2003/31]
Search report(s)International search report - published on:EP11.07.2002
ClassificationIPC:C07D235/30, C07D235/32, A61K31/4184, A61P35/00
[2003/31]
CPC:
A61K31/4184 (EP); A61P31/12 (EP); A61P35/00 (EP);
A61P35/02 (EP); C07D235/30 (EP); C07D235/32 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/31]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:BENZIMIDAZOLE UND DEREN VERWENDUNG FÜR DIE BEHANDLUNG VON KREBS ODER VIRALEN INFEKTIONEN[2003/31]
English:BENZIMIDAZOLES AND METHODS FOR USE THEREOF IN THE TREATMENT OF CANCER OR VIRAL INFECTIONS[2003/31]
French:COMPOSES ET METHODES DE TRAITEMENT DU CANCER ET D'INFECTIONS VIRALES[2003/31]
Entry into regional phase07.04.2003National basic fee paid 
07.04.2003Designation fee(s) paid 
07.04.2003Examination fee paid 
Examination procedure15.03.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
03.04.2003Amendment by applicant (claims and/or description)
07.04.2003Examination requested  [2003/31]
16.05.2006Despatch of a communication from the examining division (Time limit: M06)
16.10.2006Reply to a communication from the examining division
19.07.2007Despatch of a communication from the examining division (Time limit: M06)
30.01.2008Application deemed to be withdrawn, date of legal effect  [2008/31]
07.03.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2008/31]
Fees paidRenewal fee
12.09.2003Renewal fee patent year 03
28.09.2004Renewal fee patent year 04
14.09.2005Renewal fee patent year 05
11.09.2006Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.09.200707   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DA]US5767138  (CAMDEN JAMES BERGER [US]) [DA] 1,4,6-12 * column 2, lines 1-40 * * column 5 - column 6; tables 1,2 *;
 [A]WO9851303  (PROCTER & GAMBLE [US], et al) [A] 1,4,6-12 * page 6 * * page 20 - page 31; examples 1-5 *;
 [X]US3399212  (HOOVER JOHN R E, et al) [X] 1,4,8,9 * intermediate compounds II; column 1, line 33 - column 2, line 10 * * intermediate in example 2; primary reaction products of benzimidazoles and isocyanates in example 5 *;
 [X]US3480642  (STEDMAN ROBERT JOHN) [X] 1,7 * intermediate compounds II; column 1, line 50 - column 2, line 30 * * primary reaction products in examples 3 and 4 *;
 [X]GB1397886  (BAYER AG) [X] 1,4,7,9 * compounds II; page 1 * * page 2, line 20 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.